Compare Atomera Incorporated (ATOM) vs BridgeBio Pharma Inc (BBIO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Atomera Incorporated vs BridgeBio Pharma Inc — how do they compare? Atomera Incorporated trades at $6.48 (market cap $241.98M), while BridgeBio Pharma Inc trades at $84.09 (market cap $16.27B). The key difference: BridgeBio Pharma Inc is far larger — about 67.2× Atomera Incorporated's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Atomera Incorporated nearer its low. Which is the better fit depends on your goals.
| ATOM | BBIO | |
|---|---|---|
Market Cap | $241.98M | $16.27B |
Sector | Technology | Health |
52-Week High | $12.11 | $90.17 |
52-Week Low | $1.99 | $44.81 |
Enterprise Value | $202.19M | $17.82B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Atomera Incorporated
Atomera is a semiconductor materials engineering company. Its Mears Silicon Technology (MST) is a patented thin film that enhances transistor performance, power efficiency, and cost for global chip manufacturers.
Read more on ATOM →About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →
